Pulmatrix, Inc. (NASDAQ:PULM) recovered 52.78% of its value since hitting low of $0.72. The recent move of -4.35% drop pushed the stock to close at $1.1 when trading ended on 5/15/2019. At a recent session, the prices were hovering between $1.06 and $1.16. This company shares are 1900% off its target price of $22 and the current market capitalization stands at $10.3M. The recent change has given its price a -13.68% deficit over SMA 50 and -84.01% deficit over its 52-week high. The stock witnessed 1.85% gains, 35.77% gains and -72.64% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found PULM’s volatility during a week at 6.44% and during a month it has been found around 6.61%.

Pulmatrix, Inc. (PULM) Top Holders

Institutional investors currently hold around $1 million or 16.5% in PULM stock. Look at its top three institutional owners: Polaris Venture Management Co. V, L.L.C. owns $413 thousand in Pulmatrix, Inc., which represents roughly 4.01% of the company’s market cap and approximately 41.3% of the institutional ownership. Similar statistics are true for the second largest owner, Armistice Capital, Llc, which owns 172,325 shares of the stock are valued at $198 thousand. The third largest holder is Vanguard Group Inc, which currently holds $68 thousand worth of this stock and that ownership represents nearly 0.66% of its market capitalization.

Pulmatrix, Inc. 13F Filings

At the end of December reporting period, 5 institutional holders increased their position in Pulmatrix, Inc. (NASDAQ:PULM) by some 212,014 shares, 12 decreased positions by 119,810 and 7 held positions by 367,778. That puts total institutional holdings at 699,602 shares, according to SEC filings. The stock grabbed 1 new institutional investments totaling 172,325 shares while 8 institutional investors sold out their entire positions totaling 110,881 shares.

Pulmatrix, Inc. (NASDAQ:PULM) Insider Trades

Multiple company employees have indulged in significant insider trading. Pulmatrix, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that 10% Owner Oculus Innovative Sciences, In has sold 1,650,000 shares of Pulmatrix, Inc. (PULM) in the trading session dated Jun. 17, 2015. These shares are worth $4,537,500 and were traded at $2.75 each. The SEC filing shows that GILLIS STEVEN performed a purchase of 29,100 shares. The Director added these shares by way of transaction on Jun. 16, 2015. The company’s shares were assimilated at $17.2 per share worth to an investment of some $500,520 to the account of GILLIS STEVEN.

Director, ROCKLAGE SCOTT M, purchased 15,522 common shares of Pulmatrix, Inc. (PULM) in the open market. In a transaction dated Jun. 16, 2015, the shares were bought at an average price of $17.2, giving away a sum of $266,978. After this purchase, 67,549 common shares of PULM are directly owned by the insider, with total stake valued at $74,304.

In the transaction dated Jun. 16, 2015, a great number of shares acquired came courtesy the Director; Maki David added a total of 29,100 shares at an average price of $17.2, amounting to approximately $500,520. The insider now directly owns 87,278 shares worth $96,005.

Pulmatrix, Inc. (PULM) Analyst Guide

Not many analysts have released their opinion on Pulmatrix, Inc. (NASDAQ:PULM), with 0 analysts believing it is a strong buy. Whereas 0 of them predict the stock is a hold. Also, there are 1 buy, 0 sell and 0 strong sell ratings, collectively assigning a 2 average brokerage recommendation [T1].